The largest database of trusted experimental protocols

Slide a lyzer cassette

Manufactured by Thermo Fisher Scientific
Sourced in United States

Slide-A-Lyzer cassettes are a dialysis device used for the purification and concentration of proteins, peptides, and other biomolecules. They provide a convenient and efficient way to remove low-molecular-weight contaminants from sample solutions.

Automatically generated - may contain errors

59 protocols using slide a lyzer cassette

1

Covalent Antibody-Payload Conjugation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the generation of covalently linked antibody-payload combinations, 52+2 Cys mutated antibodies were dialyzed into complexation buffer (50 mM Tris-HCl, pH 8.5, 1 mM EDTA) using Slide-A-Lyzer cassettes (30K MWCO; Thermo Fisher Scientific). Dialysis was carried out in 2 steps for 3–5 hours and overnight at 4°C. The protein concentration of the antibody solution was adjusted to 5–10 mg/ml. The respective payload was solubilized in a suitable buffer (usually complexation buffer) at a concentration of 10 mg/ml. Payload that were not soluble in aqueous buffer were solubilized in 100% DMF (anhydrous; Solulink). Immediately after solubilization, the solutions were mixed at a molar ratio of 1:2.5 antibody/payload while slowly agitated by shaking or stirring with a polytetrafluorethylen (PTFE) stirrer bar. The mixture was incubated for 1 hour at 25°C. Subsequently, the buffer was exchanged to 20 mM histidine, 140 mM NaCl pH 6.0 either by dialysis (Slide-A-Lyzer cassettes, 30K MWCO; Thermo Fisher Scientific) or by size exclusion chromatography (Superdex 200; GE Healthcare) depending on the scale of the reaction. Characterization of the samples was carried out by fluorescent SDS-PAGE or Western blot and mass spectrometry analysis.
+ Open protocol
+ Expand
2

Radiolabeling Antibodies via DTPA Conjugation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To prevent contaminants from disturbing radiolabeling, 1 mg of mIgG1 PD-L1-srt-his and rIgG2a WT antibodies were dialyzed against 5 L sterile PBS (metal-free) using Slide-a-Lyzer Cassettes (ThermoFisher Scientific). Subsequently, a 15 eq. of S-2-(4-Isothiocyanatobenzyl)-diethylenetriamine pentaacetic acid (p-SCN-Bn-DTPA, Macrocyclics, B-305) and 1/10 reaction volume 1 M NaHCO3 in PBS, pH 5.5 were added to each antibody and incubated for 1 h at RT. Non-conjugated p-SCN-DTPA was removed from the reaction mixture by dialysis against 5 L 0.25 M NH4Ac (metal-free, pH 5.5) using Slide-a-Lyzer Cassettes (ThermoFisher Scientific). After dialysis, concentration in all samples was determined via spectrophotometer.
+ Open protocol
+ Expand
3

Antibody Buffer Exchange and Stability Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To buffer exchange the 1 M arginine stabilized antibody into the test single buffer species formulation buffers, a 3 mL aliquot of IgG3 at 2 mg/mL or above was loaded into a 10 kDa molecular weight cutoff Slide-A-Lyzer cassette (Thermo Scientific, Rockford, IL). It was dialyzed in the test formulation buffer overnight, equivalent to an 18,000-fold buffer exchange. Dialyzed samples were collected, weighed to determine postdialysis volume, and visually inspected for the presence of gross precipitate and opalescence. To monitor long-term stability, SEC, Protein A, and absorbance measurements at 280 nm (protein content) and 410 nm (opalescence) were performed at day 0 (T0), 30 days in 4°C (T30), and after three cycles of freezing (−80°C held for 2 hours) and thawing (F/T) (37°C for 10 minutes) for the arginine and histidine buffer formulations. The remaining 9 acetate formulations were not fully tested based on initial analytics indicating decreased stability of the antibody at T0.
+ Open protocol
+ Expand
4

DOTA Conjugation of Trastuzumab

Check if the same lab product or an alternative is used in the 5 most similar protocols
850 μL trastuzumab (23.5 mg/mL in saline) was dialysed overnight in a 3.5 kDa MWCO Slide-a-lyzer™ cassette (ThermoFisher, USA) against 0.2 M, pH 5.5 sodium acetate containing 2 g/L chelex (Sigma, UK). DOTA conjugation to trastuzumab (10 mg, 12.8 mg/mL) was achieved by incubating a reaction solution containing a 40:1 M ratio of chelator to antibody, i.e. 1.1 mg DOTA (p-SCN-Bn-DOTA, Macrocyclics, USA; 110 mg/mL in 0.25 M pH 5.5 sodium acetate) to which 83 μL 1 M NaHCO3, pH 9.5 was added and the mixture stirred for 60 min at room temperature. The conjugated antibody was dialysed against 0.2 M, pH 5.5 ammonium acetate containing 2 g/L chelex to remove unbound p-SCN-Bn-DOTA, furnishing a 13.5 mg/mL DOTA-trastuzumab solution (measured by NanoDrop).
+ Open protocol
+ Expand
5

Silk Fibroin Solution Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Silk fibroin aqueous solution was obtained from B. mori silkworm cocoons according to previously published literature (Di Buduo et al., 2018 (link)). Briefly, dewormed cocoons were boiled for 30 min in 0.02 M Na2CO3 solution at a weight to volume ratio of 10 g to 4 L. The fibers were rinsed for 20 min three times in ultrapure water and dried overnight. The dried fibers were solubilized for 4 hr at 60°C in 9.3 M LiBr at a weight to volume ratio of 3 g/12 mL. The solubilized silk solution was dialyzed against distilled water using a Slide-A-Lyzer cassette (Thermo Scientific, Waltham, MA, USA) with a 3500 MW cutoff for three days and changing the water a total of eight times. The silk solution was centrifuged at maximum speed for 15 min to remove large particulates and stored at 4°C. The concentration of the silk solution was determined by drying a known volume of the solution overnight at 60°C and massing the remaining solids.
+ Open protocol
+ Expand
6

Silk Fibroin Aqueous Solution Extraction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Silk fibroin aqueous solution was obtained from B. mori silkworm cocoons according to previously published literature [22 (link)–24 (link)]. Briefly, dewormed cocoons were boiled for 10 min in 0.02 M Na2CO3 solution at a weight to volume ratio of 5 g to 2 L. The fibers were rinsed for 20 min for three times in ultrapure water and dried overnight. The dried fibers were solubilized for 4 h at 60 °C in 9.3 M LiBr at a weight to volume ratio of 3 g–12 mL. The solubilized silk solution was dialyzed against distilled water using a Slide-A-Lyzer cassette (Thermo Scientific, Waltham, MA, USA) with a 3500 MW cutoff for three days and changing the water a total of eight times. The silk solution was centrifuged at maximum speed for 10 min to remove large particulates and stored at 4 °C. The concentration of the silk solution was determined by drying a known volume of the solution and massing the remaining solids.
+ Open protocol
+ Expand
7

Recombinant Expression and Purification of PduC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genes encoding wildtype and catalytically-inactive PduC were cloned with pduDE into the pET30b expression system (Novagen) and transformed into E. coli BL21 containing the λDE3 lysogen. A starter culture in LB with kanamycin was subcultured into LB with kanamycin and 0.1% 1,2-propanediol and incubated at 37°C with shaking until OD600 = 0.9 then 1 mM IPTG was added to induce expression. The culture was incubated an additional 6 hours. Protein was purified as previously described (Levin and Balskus, 2018 (link)). Briefly, bacterial cells were spun down and washed with buffer (50 mM potassium phosphate, pH 8, 2% 1,2-propanediol) then resuspended in lysis buffer (50 mM potassium phosphate, pH 8, 2 mM EDTA, 2 mM PMSF, 2% 1,2-propanediol), sonicated, and ultra-centrifuged for 30 minutes at 100,000 × g. Supernatants were transferred to a 10 kDa Slide-A-Lyzer cassette (Thermo Fisher) and dialyzed against buffer (50 mM potassium phosphate, pH 8, 0.1% Brij 35). Protein purity was assessed by SDS-PAGE and concentration was determined by Pierce BCA Protein Assay (Thermo Fisher).
+ Open protocol
+ Expand
8

Silk Fibroin Extraction from Silkworms

Check if the same lab product or an alternative is used in the 5 most similar protocols
Silk fibroin aqueous solution was obtained from Bombyx mori (CREA – AA), as previously described.[35 (link)
] Briefly, dewormed cocoons were boiled in Na2CO3. The fibers were rinsed in ultrapure water and dried overnight. The dried fibers were solubilized in LiBr. The solubilized silk solution was dialyzed against distilled water using a Slide‐A‐Lyzer cassette (Thermo Scientific) with a 3500 MW cutoff for three days. Before usage, the silk solution was centrifuged at maximum speed to remove large particulates.
+ Open protocol
+ Expand
9

Tracking endocytic pathway with BafA1 and BSA

Check if the same lab product or an alternative is used in the 5 most similar protocols
U2OS cells were treated for 2.5, 5, 10 or 24 h with 200 nM BafA1 in the culture medium. Starvation was induced by changing the culture medium to EBSS in the last 2.5 h of BafA1 treatment. In an additional experiment, 2.5 h BafA1 treatment was combined with addition of the endocytic marker BSA5 using a pulse-chase protocol. Stock solution of BSA5 was dialyzed ON in a Slide-A-Lyzer cassette (Thermo Fisher Scientific, 66383) in PBS to remove NaN3 and diluted to an OD600 of 4–4.5 in DMEM. The BSA5 solution was applied to U2OS cells for 1.5 h, followed by a short rinse with DMEM and a chase of 5.5 h. During the last 2.5 h of the 5.5 h chase, the cells were starved by switching from DMEM to EBSS in the presence of 200 nM BafA1 and subsequently fixed.
+ Open protocol
+ Expand
10

Affinity Purification of His-Tagged Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cleared lysate was loaded onto Ni-NTA resin (Superflow, IBA) which was preconditioned with water and 1x native lysisbuffer. Binding was performed overnight at +4 °C under continuous agitation. Next day, the resin was settled vertically and washed with 6 bed volumes of lysisbuffer containing 20 mM of Imidazole. Thereafter, the bound recombinant protein was eluted with 4 bed volumes of elution buffer (500 mM of NaCl, 50 mM phosphate buffer (pH 8.0), 5 % v/v glycerol and 300 mM of Imidazole). Subsequently, salts were removed by dialysis in a Slide-a-Lyzer cassette (3,500 MWCO, 3–12 ml capacity, ThermoScientific) for 48 h at +4 °C. The dialysis buffer (PBS complemented with 0.1 M NaCl and 5 % v/v glycerol) was refreshed three times. After dialysis the recombinant protein content was analyzed for protein concentration (BCA assay, ThermoScientific) and Western Blot. A second round of purification was performed by fast protein liquid chromatography (FPLC) with a 1 ml volume HisTrap-HPTM column (GE Health Care life sciences) with a pressure flow of 0.15 ml/min. The his-tagged proteins were eluted from the column with 10 column volumes (CV) of a linear gradient ranging from 50 mM Imidazole up to 500 mM Imidazole in 0.5 ml aliquots. These were analyzed by Western blot and the eluates containing the his-tagged proteins were subsequently pooled and dialyzed as described above.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!